Horizon is in the process of completing clinical trials on a new blockbuster. It's true. Reportedly it will be in line with the cost of other biologics... About 8000-10000 a dose. It will jump the stock price close to 60 a share, according to Reuters!!! Finally...they prove themselves as the bio pharmaceutical company that Tim has been claiming all along. Obviously there is no brand name yet, but it's listed as HZN463. It's a combination of salicylic acid and cimetidine.....aspirin and Tagamet. If you arthritis sufferers can't wait, you can find it down aisle four at Walmart. Herrrrizzzzon. Lol.
Phase IV Clinical Trials HZN463....$60 share soon
Aucun commentaire:
Enregistrer un commentaire